biopharma

Cognizant has announced an expansion of its relationship with biopharmaceutical company Gilead Sciences. Under the agreement, Cognizant will manage Gilead’s global IT infrastructure, platforms, applications and advanced analytics and lead…

Syngene International, a subsidiary of Biocon Ltd., has decided to acquire a Unit 3 biologics manufacturing facility in Bengaluru from Stelis Biopharma Limited (SBL) on a slump sale basis for a gross value of ₹702 crore.The deal, which is…

A messy legal fight over the Food and Drug Administration's approval of the abortion pill mifepristone poses risks to the biopharma industry that go beyond the single drug.If a subsequent decision tosses out the pill's approval, it could…

The biotech company that makes mRNA-delivery technology for Pfizer‘s PFE.N COVID-19 vaccine sued Arbutus Biopharma Corp ABUS.O in Manhattan federal court on Friday, seeking to head off claims that the vaccine infringes Arbutus’…

President of the Boston-based USAIC Karun Rishi, however, said it is a matter of concern that the Budget lacks tangible measures to increase revenue generation. In the midst of third wave of COVID-19, Finance Minister Nirmala…

DRL gets rights to commercialise proposed trastuzumab biosimilar in select LatAm, S-E Asia markets. Pharma major Dr. Reddy’s Laboratories has entered into a partnership with Prestige BioPharma under which it will get exclusive rights…

The government has permitted the export of Russia's single-dose COVID-19 vaccine Sputnik Light domestically produced here as the jab has not yet been approved for emergency use in India, sources said on Sunday. Indian drug firm Hetero…

NEW DELHI : As new Indian and global pharmaceutical companies include vaccines as a key part of their portfolios, India’s vaccines industry can grow from $2 billion to $4 billion or even $5 billion, said a report…